Edition:
United States

People: Eisai Co Ltd (4523.T)

4523.T on Tokyo Stock Exchange

6,182JPY
10:29pm EDT
Change (% chg)

¥113 (+1.86%)
Prev Close
¥6,069
Open
¥6,190
Day's High
¥6,386
Day's Low
¥6,178
Volume
1,039,000
Avg. Vol
698,017
52-wk High
¥7,280
52-wk Low
¥5,496

Kai, Yasunobu 

Mr. Yasunobu Kai has been serving as Executive Officer, Chief Planning Officer of Oncology Business Group and Director of Planning of Oncology Business Group in Eisai Co., Ltd. since May 2017. He joined the Company in April 1986. His previous titles include President of Frontier Drug Development Unit and President of Eisai Value Maximization Systems in the Company.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --